RAINMED-B Maintains Steady Share Capital in July; Confirms Public Float Compliance

Bulletin Express08-03

Rainmed Medical Limited (abbreviation: RAINMED-B) submitted its monthly return for the period ended 31 July 2026, confirming no changes to its share capital structure and compliance with Hong Kong Stock Exchange public float requirements.

Total authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 0.38 million. Issued share capital was unchanged at 1.40 billion shares, and the company held no treasury shares.

RAINMED-B affirmed that more than the minimum 25% public float threshold stipulated under Main Board Rule 13.32B was maintained throughout the month.

Under the Pre-IPO Share Option Scheme adopted on 10 December 2021 (exercise price: HKD 3.90), 21.72 million options were outstanding as at 31 July 2026. There were no option exercises, cancellations, or new grants during the month, leaving the potential dilution unchanged. No warrants, convertible securities, or other equity-linked instruments were outstanding or issued.

The monthly return, filed on 3 August 2026 by Joint Company Secretary Zhang Liang, states that all regulatory and listing rule obligations have been duly met.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1179803311?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-03 17:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179803311","market":"hk","top_or_hot":-1,"title":"RAINMED-B Maintains Steady Share Capital in July; Confirms Public Float Compliance","media":"Bulletin Express","content":"<p>Rainmed Medical Limited (abbreviation: RAINMED-B) submitted its monthly return for the period ended 31 July 2026, confirming no changes to its share capital structure and compliance with Hong Kong Stock Exchange public float requirements.</p>\n<p>Total authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 0.38 million. Issued share capital was unchanged at 1.40 billion shares, and the company held no treasury shares.</p>\n<p>RAINMED-B affirmed that more than the minimum 25% public float threshold stipulated under Main Board Rule 13.32B was maintained throughout the month.</p>\n<p>Under the Pre-IPO Share Option Scheme adopted on 10 December 2021 (exercise price: HKD 3.90), 21.72 million options were outstanding as at 31 July 2026. There were no option exercises, cancellations, or new grants during the month, leaving the potential dilution unchanged. No warrants, convertible securities, or other equity-linked instruments were outstanding or issued.</p>\n<p>The monthly return, filed on 3 August 2026 by Joint Company Secretary Zhang Liang, states that all regulatory and listing rule obligations have been duly met.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RAINMED-B Maintains Steady Share Capital in July; Confirms Public Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRAINMED-B Maintains Steady Share Capital in July; Confirms Public Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-03 17:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Rainmed Medical Limited (abbreviation: RAINMED-B) submitted its monthly return for the period ended 31 July 2026, confirming no changes to its share capital structure and compliance with Hong Kong Stock Exchange public float requirements.</p>\n<p>Total authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 0.38 million. Issued share capital was unchanged at 1.40 billion shares, and the company held no treasury shares.</p>\n<p>RAINMED-B affirmed that more than the minimum 25% public float threshold stipulated under Main Board Rule 13.32B was maintained throughout the month.</p>\n<p>Under the Pre-IPO Share Option Scheme adopted on 10 December 2021 (exercise price: HKD 3.90), 21.72 million options were outstanding as at 31 July 2026. There were no option exercises, cancellations, or new grants during the month, leaving the potential dilution unchanged. No warrants, convertible securities, or other equity-linked instruments were outstanding or issued.</p>\n<p>The monthly return, filed on 3 August 2026 by Joint Company Secretary Zhang Liang, states that all regulatory and listing rule obligations have been duly met.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02297","symbol_name":"润迈德-B","start_time":0,"source_url":"","article_id":"1179803311","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179803311","pubTimestamp":1785750283,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Rainmed Medical Limited (abbreviation: RAINMED-B) submitted its monthly return for the period ended 31 July 2026, confirming no changes to its share capital structure and compliance with Hong Kong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02297":"润迈德-B"},"translate_title":"RAINMED-B 7月份股本保持稳定；确认公众持股量合规性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02297":1},"content_text":"Rainmed Medical Limited (abbreviation: RAINMED-B) submitted its monthly return for the period ended 31 July 2026, confirming no changes to its share capital structure and compliance with Hong Kong Stock Exchange public float requirements.\nTotal authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 0.38 million. Issued share capital was unchanged at 1.40 billion shares, and the company held no treasury shares.\nRAINMED-B affirmed that more than the minimum 25% public float threshold stipulated under Main Board Rule 13.32B was maintained throughout the month.\nUnder the Pre-IPO Share Option Scheme adopted on 10 December 2021 (exercise price: HKD 3.90), 21.72 million options were outstanding as at 31 July 2026. There were no option exercises, cancellations, or new grants during the month, leaving the potential dilution unchanged. No warrants, convertible securities, or other equity-linked instruments were outstanding or issued.\nThe monthly return, filed on 3 August 2026 by Joint Company Secretary Zhang Liang, states that all regulatory and listing rule obligations have been duly met.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1179803311","isCrawlerRequest":true}